Stock Market Analysis Video 3/11/2011

The stock charts used in this presentation are provided by WONDA ® Copyright © 2016 William O’Neil + Co., Inc. All rights reserved. Unauthorized duplication, modification, photocopying or distribution in any form is strictly prohibited.

Learn more about Mike's stocks here: Cabot Market Letter 

Editor Mike Cintolo says it is certainly an interesting time in the market. On one hand, there is a lot of distribution with many breakdowns among some large indexes and key leading stocks. On the other hand, there are leading stocks that are resisting the market's three-week decline. Stocks discussed are Finisar (FNSR), Salesforce.com (CRM), F5 Networks (FFIV), Priceline.com (PCLN), OpenTable (OPEN), Baidu (BIDU), Sina Corp. (SINA), Under Armour (UA), Lululemon Athletica (LULU) and Polo Ralph Lauren (RL).

Mike CintoloMichael Cintolo
Vice President of Investments, Editor of Cabot Market Letter and Cabot Top Ten Report

A growth stock and market timing expert, Michael Cintolo is editor of Cabot Market Letter and Cabot Top Ten Report. Since joining Cabot in 1999, Mike has uncovered exceptional growth stocks and helped to create new tools and rules for buying and selling stocks. Perhaps most notable was his development of the proprietary trend-following market timing system, Cabot Tides that has helped Cabot place among the top handful of market-timing newsletters numerous times. Cabot Market Letter is one of only nine newsletters included in Hulbert Financial Digest's 2010 Honor Roll for performance in up and down markets, and Timer Digest Top Ten Long-Term Timer.


~~~~~~~~~~~


And now a word from : Timothy Lutts, Cabot President and Chief Investment Strategist


Dear Cabot Wealth Advisory Reader,

There are many ways to make money in the market, and in my decades at Cabot, I’ve been part of a lot of them.

I helped subscribers accumulate profits of 1291% in Amazon.com over the course of two years (boy, the late ’90s were fun.)

I helped subscribers amass profits of 560% in Qualcomm in nine months.

And I helped subscribers rack up gains of 189% in Taser (zap!!) in just eight weeks.

But until last month I’d never seen anyone pile up profits of 181% in just 18 trading days!

And that’s because I’d never had a guide to the world of options trading, where you can bet on the ups AND the downs of the market, and where the profits can pile up faster than snow in a New England winter.

But now I have. And I’ve got to say, I’ve been impressed, so impressed that I’ve launched a new advisory letter dedicated to options trading, and edited by the trading expert who showed me, in real time, what these powerful instruments can do, when handled properly.

Click below to learn more about this exciting new product.

Order Now Learn More


Best wishes with all of your investments,

Timothy Lutts

Timothy Lutts
Publisher

P.S. If you’re saying to yourself, “Maybe I’ll try it later, when the market is healthier,” consider this: Cabot Options Trader makes money in ups AND downs of the market. Don’t miss a single issue.

Stock Picks

General Motors

The top dividend stock in the auto industry is General Motors (GM), a leader in big high-margin models, both in the U.S. and in China.

Anheuser-Busch Inbev

Revenues at the company fell 7% last year, while earnings shrank 4%, but the stock is holding up surprisingly well.

Monster Beverage

Thanks to its Coca-Cola agreement, Monster Energy drinks will hit shelves in Australia and New Zealand later this month.

Cabot Wealth Advisory

Grace Groner and the Power of Dividend Reinvestment Plans

By Paul Goodwin on May 27, 2016

Buying and holding stocks and enrolling in dividend reinvestment plans aren't exciting ways to invest, but they're an effective way to build long-lasting wealth. For evidence, look no further than Grace Groner. Read More >

One of the Leading Biotech Stocks Is Now on Sale

By J. Royden Ward on May 26, 2016

Standard & Poor’s lists a whopping 196 biotechnology companies in its database, but AbbVie (ABBV) stands out above the rest. The company is growing rapidly but due to the correction in biotech stocks, it’s now an undervalued stock.Read More >

The Best Small-Cap Dividend Stocks to Buy Now

By Tyler Laundon on May 24, 2016

While small-cap dividend stocks don’t always make for juicy storylines, the fact is that many of the best performers in the stock market today are these little income producers. And if you have the willpower to stick with them, you may easily find their performance rivals that of the best performing growth stocks. Here are three stocks for your review. Read More >